Under current laws, a company cannot sell mines but only transfer leases when it is acquired by another firm.
A full-blown recovery remained elusive for India Inc in the July-September quarter, even as it overcame the challenge of achieving profitable growth.
With mutual funds, promoters turning net-buyers, foreign investors may have to bid up prices to raise holdings.
Decades of a state-owned monopoly selling coal at a fixed price has taken its toll on production.
The analysis covers BSE 200 Index's 171 companies for which data on the compensation to the boards of directors for FY14 and FY13 are available.
India Inc gets about Rs 67,000 crore worth of fresh orders in the Sept quarter, a rise of 45% sequentially.
China has cast a long shadow on India's economy.
Impact of the slowdown is most visible among promoter/owner-CEOs
The new system will entail a periodic revision in the price of subsidised LPG cylinders so that the subsidy remains fixed.
That resulted in a 50-basis point improvement in operating profit margins on a sequential basis.
Firms generated free cash flows in 2013-14, for the first time since the 2008 Lehman crisis
Mid- and small-cap funds dominate the list, opening up opportunity for investors to make contra bets in large-cap funds
Many say Tata Motors has perhaps paid the price for being too ambitious.
With the Supreme Court (SC) cancelling captive coal block allocations, Jindal Steel & Power Limited will be the worst-affected company.
It is up to the government to take a decision on this before it starts auctioning.
The Supreme Court order has created a new legal framework for coal mining by ruling that only the Union government and its entities can do it.
Their share in overall market capitalisation of BSE stocks has risen to a four-year high
The Supreme Court is expected to deliver its final verdict on coal mine allocations later this week.
Top companies in China are valued at 7.7 times the trailing 12-month earnings against a P/E ratio of 18.6 times for Nifty 50 companies.
Shree Cement beats ACC in market value, Lupin ahead of Dr Reddy's Labs
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances